Pain & MusculoskeletalHowever, these descriptive patterns do not establish treatment efficacy or the certainty of the underlying evidence.
Review · October 15, 2026 · Song E et al.
Pain & MusculoskeletalLaser therapy provides modest, reproducible analgesic benefits, and selective ROM improvements, particularly when HLLT is combined with exercise.
Review · September 26, 2026 · Dadkhahfar S et al.
Skin & Wound HealingHigh fluences of 405 nm blue light photobiomodulation was generally well tolerated in this small cohort and was considered safe for use in patients with chronic wounds.
Trial · September 11, 2026 · Plum F et al.
Brain & NeurologyPBM appears safe, feasible, and acceptable in PD, but current evidence does not support clinically meaningful motor benefits. Heterogeneous protocols, small samples, and absent target-engagement biomarkers limit definitive interpretation.
Review · August 31, 2026 · Mariano J et al.
OtherFindings will contribute to future trial designs and support the development of standardized protocols for PBM applications in ophthalmology.
Study · August 12, 2026 · Chun JM et al.
Pain & MusculoskeletalPreliminary evidence suggests green light therapy is a promising and accessible nonpharmacological approach for pain or pain-related psychosocial outcomes but remains insufficient to establish the efficacy of green light therapy.
Review · July 21, 2026 · Bain J et al.
Safety & EvidencePBMT appears to reduce pain, edema, ecchymosis, and improve wound healing after facial surgery; however, current evidence is sparse and requires validation in larger cohorts.
Review · July 10, 2026 · Knoedler L et al.
Skin & Wound HealingBoth fractional CO₂ laser and microneedling procedures show comparable efficacy in treating atrophic acne scars, however, patient variables such as skin type, scar type, and possible complications should be taken into consideration.
Review · June 23, 2026 · Batool A et al.
Pain & MusculoskeletalPBMT may reduce pain during local anesthetic needle puncture. However, substantial heterogeneity, wide prediction intervals, and methodological limitations reduce confidence in the findings.
Review · June 7, 2026 · Nascimento MFDS et al.
Devices & DosimetryBoth pulse durations effectively reduced erythema, but 10 ms demonstrated more favorable tolerability.
Trial · May 11, 2026 · Liu T et al.
Skin & Wound HealingDespite the encouraging results, the scarcity of specific studies and the absence of robust randomised clinical trials underscore the need for further research to validate its effectiveness and establish consistent clinical protocols.
Review · May 1, 2026 · Silva JEC et al.
Brain & NeurologyAmong the interventions evaluated, photobiomodulation and enriching environment were associated with better improvements in cognitive function than pharmacological therapy.
Review · April 11, 2026 · Zhao Y et al.
OtherPBM shows potential as an adjunctive therapy for glycemic control in T2DM, although further well-designed trials are required to strengthen evidence and standardize protocols.
Review · March 20, 2026 · da Rocha FC et al.
OtherIn conclusion, physical modalities - particularly LLLT and mechanical vibration - can moderately accelerate upper canine retraction without detectable adverse effects.
Review · March 6, 2026 · Almasri AMH et al.
Pain & MusculoskeletalBased on the current evidence, both HILT and LLLT may be considered therapeutic options for pain management in MSDs; however, treatment decisions should be made cautiously within a multimodal rehabilitation framework.
Review · February 16, 2026 · de la Barra Ortiz HA et al.
Pain & MusculoskeletalPBM has analgesic potential and a safe profile for managing chronic pain, especially in cases difficult to control with conventional therapies.
Review · February 3, 2026 · Ferreira LMA et al.